Key result
Heart failure prevalence in Russia reaches ~7% though national coding systems limit accurate mortality tracking.
Why the study?
Data on the epidemiology of heart failure and related mortality in Russia are limited, and heart failure recognition is hindered by peculiarities of the national mortality coding system.
Highlights the 7% prevalence of heart failure in Russia and discusses challenges in mortality coding and statistical reporting.
Limited Russian mortality coding cautions against precise HF burden estimates; leaves open improved surveillance for accurate tracking.
The increasing prevalence of heart failure (HF) serves as a reverse side of the effective treatment for cardiovascular diseases (CVD) and increasing patient survival. Data on the epidemiology of HF and related mortality in Russia are limited. According to the EPOCHA trial (hospital phase), the prevalence of HF in the Russian Federation is 7%. HF can significantly contribute to cardiovascular mortality. However, its recognition is limited by the peculiarities of the mortality coding system in Russia. The article presents the authors’ view on the registration of HF-related morbidity and mortality cases and perspectives of using left ventricular ejection fraction <50% for statistical reporting.
No takes yet. Share an insight, caveat, or question.
Shlyakhto et al. (2020) conducted a review in Heart failure. The prevalence of heart failure in the Russian Federation is estimated at 7%, though accurate mortality tracking is limited by the national mortality coding system.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: